Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04150614 · ClinicalTrials.gov registry record · Phase 4
BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron
A Phase 4 study of Nausea With Vomiting Chemotherapy-Induced, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04150614 is a Phase 4 study of Nausea With Vomiting Chemotherapy-Induced that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04150614, a Phase 4 study of Nausea With Vomiting Chemotherapy-Induced, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients undergoing either an autologous or allogeneic hematopoietic stem cell transplant (HSCT) and receiving preparative chemotherapy experience a considerable amount of chemotherapy-induced nausea and vomiting (CINV). Current strategies at reducing CINV in this patient population are suboptimal due to lack of efficacy and supportive evidence, potential for increased adverse events, and drug-drug and drug-disease contraindications.
Conditions Studied
Interventions
- DRUG Ondansetron
- DRUG Granisetron Transdermal Patch
- DRUG Intravenous Dexamethasone
Study Locations (1)
Illinois
- University of Illinois Cancer Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2020-05-14 |
| Est. Completion | 2026-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04150614
The ClinicalTrials.gov registry entry for NCT04150614 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nausea With Vomiting Chemotherapy-Induced appearing as the primary indexed condition, and to 3 interventions - of which Ondansetron is the first listed.
NCT04150614 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04150614 about?
NCT04150614 is a clinical study titled "BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron". Patients undergoing either an autologous or allogeneic hematopoietic stem cell transplant (HSCT) and receiving preparative chemotherapy experience a considerable amount of chemotherapy-induced nausea and vomiting (CINV). Current strategies at reducing CINV in this patient population are suboptimal d...
What is the current status of trial NCT04150614?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2020-05-14. Estimated completion is 2026-07.
What conditions does trial NCT04150614 study?
This clinical trial studies the following conditions: Nausea With Vomiting Chemotherapy-Induced.
What interventions are being tested in trial NCT04150614?
The interventions under investigation include: Ondansetron (DRUG), Granisetron Transdermal Patch (DRUG), Intravenous Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04150614?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04150614 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.